Skincare giant Trilogy is maintaining its position in the beauty industry, with its latest figures showing profits tripling to $3.5m before tax for the six months to September 30, a huge increase compared to $1.1m for the same period last year.
As a result, shares in cosmetics and candle maker Trilogy International jumped 21 per cent from 20 cents to $1.15 shortly after the announcement. The company also expects its income to rise to more than $23 million.
Chief executive Angela Buglass spoke to Stuff, saying Trilogy’s business strategy of investing for growth is already delivering results.
“The new financial year had started well, driven by strong customer demand and expansion in key markets,” she said.
Not only a success in its hometown, Trilogy is also growing steadily in the United States and Asia. Its sister brand, Goodness Natural Beauty Lab, is also meetings its sales targets in New Zealand and Australia.
